Control Bionics Limited (CBL.AX)
AUD 0.05
(-13.46%)
AUD 0.05
(-13.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.15 Million AUD | 2.41% |
| 2023 | -5.13 Million AUD | 7.99% |
| 2022 | -5.58 Million AUD | -68.23% |
| 2021 | -3.39 Million AUD | -204.85% |
| 2020 | -989.95 Thousand AUD | 46.67% |
| 2019 | -1.92 Million AUD | -93.81% |
| 2018 | -968.42 Thousand AUD | -101.66% |
| 2017 | 63.63 Million NZD | 5.07% |
| 2016 | 60.57 Million NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -1.63 Million AUD | 0.0% |
| 2024 Q3 | -1.63 Million AUD | 33.15% |
| 2024 FY | - AUD | -17.22% |
| 2024 Q1 | -1.01 Million AUD | 63.33% |
| 2024 Q2 | -2.44 Million AUD | -142.49% |
| 2023 Q1 | -1.51 Million AUD | 50.3% |
| 2023 FY | - AUD | 7.99% |
| 2023 Q2 | -2.84 Million AUD | -88.07% |
| 2023 Q4 | -2.75 Million AUD | -151.11% |
| 2023 Q3 | -1.09 Million AUD | 61.43% |
| 2022 FY | - AUD | -68.23% |
| 2022 Q4 | -3.04 Million AUD | 0.0% |
| 2021 FY | - AUD | -204.85% |
| 2020 FY | - AUD | 46.67% |
| 2019 FY | - AUD | -93.81% |
| 2018 FY | - AUD | -101.66% |
| 2017 FY | - NZD | 5.07% |
| 2016 FY | - NZD | 0.0% |
| 2016 Q4 | 15.9 Million NZD | 0.0% |
| 2016 Q3 | 15.9 Million NZD | 0.0% |
| 2016 Q2 | 15.9 Million NZD | 5.07% |
| 2016 Q1 | 15.14 Million NZD | 0.0% |
| 2015 Q2 | 15.14 Million NZD | 0.0% |
| 2015 Q4 | 15.14 Million NZD | 0.0% |
| 2015 Q3 | 15.14 Million NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 85.698% |
| Adherium Limited | -11.56 Million AUD | 55.396% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 29.916% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 4.891% |
| Anteris Technologies Ltd | -66.9 Million AUD | 92.29% |
| CardieX Limited | -6.71 Million AUD | 23.148% |
| Compumedics Limited | 2.78 Million AUD | 284.948% |
| Cochlear Limited | 579.5 Million AUD | 100.89% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -47.723% |
| Cyclopharm Limited | -3.03 Million AUD | -69.963% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -146.662% |
| Nova Eye Medical Limited | -5.97 Million AUD | 13.728% |
| HeraMED Limited | -3.97 Million AUD | -29.862% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 76.415% |
| ImpediMed Limited | -22.05 Million AUD | 76.608% |
| InhaleRx Limited | -1.41 Million AUD | -264.862% |
| LBT Innovations Limited | -4.04 Million AUD | -27.395% |
| Micro-X Limited | -14.35 Million AUD | 64.057% |
| Neurotech International Limited | -8.24 Million AUD | 37.431% |
| OncoSil Medical Limited | -11.97 Million AUD | 56.929% |
| PolyNovo Limited | 5.17 Million AUD | 199.772% |
| Respiri Limited | -7.04 Million AUD | 26.833% |
| SomnoMed Limited | -2.32 Million AUD | -121.514% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 43.257% |
| Uscom Limited | -1.5 Million AUD | -241.759% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -4.897% |